Books by Subject

Research

  • Digital
    edited by Mohit Bhandari, Anders Joensson.
    Digital : Thieme Book2011
    Why should we publish papers? / George M. Kontakis, Peter V. Giannoudis -- Presented but never published : why research papers are not being published / Cheryl Wylie, Sheila Sprague -- What is the quality of the published orthopaedic literature? / Daniel Vena, Sheila Sprague -- Common pitfalls in the reporting of surgical results / Rudolf W. Poolman -- Overview : what to consider before you start writing / Paul Karanicolas -- Ethics in writing : maintaining credibility / Lyndsay Somerville, Dianne Bryant -- Authorship : what you should know / Rad Zdero, Emil H. Schemitsch -- When do you need a statistician? : more than just number crunchers / Jason W. Busse -- The structured abstract / Ole Brink, Lars C. Borris -- Writing an introduction / Emil H. Schemitsch, Rad Zdero -- Writing a methods section / Emil H. Schemitsch, Rad Zdero -- Results : basics of analysis / Paul Karanicolas -- Results : tables, figures, and appendices / Jacquelyn Marsh, Dianne Bryant -- How to frame a discussion / Kyle Jeray, Stephanie Tanner -- Referencing and acknowledgments / Richard Gould, Bradley Petrisor -- Author instructions / George Mathew, Sheila Sprague -- Formatting your paper : title page and more / Scott Wingerter -- Grammar police : the dos and don'ts of writing / Eric Morrison -- How to address reviewer's comments : dos and don'ts / Rad Zdero, Emil H. Schemitsch -- Getting your research accepted at scientific meetings : writing the abstract / George Mathew, Sheila Sprague -- PowerPoint presentations : tips for presenting your work / Tara M. Mastracci -- Poster presentations : preparing an effective research poster / Chad Coles -- Be consistent : present and publish the same results / Boris A. Zelle.
  • Digital
    Richard Chin, Menghis Bairu [editors].
    Digital : ScienceDirect2011
  • Digital
    by Maurice Kogan, Mary Henkel and Steve Hanney.
    Digital : Springer2006
  • Print
    Print2007
    Status: Not Checked OutLane Catalog Record
  • Print
    Stephen W. Russell, DVM, PhD, David C. Morrison, PhD.
    Print2016
    Before you begin to write overview. Finding NIH funding opportunities and responding to them; How to develop an irresistible idea for your grant application; How to find the appropriate program and grant application; How to find the appropriate program and grant mechanism for your idea; Influence of the NIH review process on writing for success; Response to prior review; Create a writng schedule; The template for your research plan overview. Specific aims section: Conceptual framework for creating a bulleted outline; Writing the specific aims section; Development of the rest of your application overview. Strategic use of literature review and preliminary results; Bibliography & References cited section; Research strategy section: Significance (including scientific premise) and innovation subsections; Research strategy section: Approach subsection (Including Rigor, potential biological variables, technical preliminary studies, and renewal progress report); Senior/key person profile(s) form, biographical sketches, and multiple PD/PI leadership plan of the PHS 398 research plan form; PHS 398 modular budget form and budget justifications; SF 424 R & R [breakout] budget form and R & R subaward budget attachment(s) form; Project/performance site location(s) form; Facilities & other resources, equipment, environment impact, historical places, and foreign components sections of the R & R other project information form; Human subjects section, Vertebrate animals, select agent research, consortium/contrctual arrangements, resource sharing plan(s), Authentication of key biological and/or chemical resources, and appendix sections of the PHS 398 research plan form; SF 424 (R & R) [cover] form, the PHS 398 cover page supplement form, and the PHS assignment request form; Maximizing your application's competitiveness; How to create a compelling, informative title for your proposal; Project summary/abstract, project narrative, and proprietary/privileged information; Cover letter attachment and letters of support; Pre-supmission review and subbmission of your application; allowability of post-submission materials.
  • Print
    edited by Adele E. Clarke and Kathy Charmaz.
    Status: Not Checked OutLane Catalog Record
    v. 1. History, essential and debates in grounded theory -- v. 2. Grounded theory in disciplines and research -- v. 3. Grounded theory exemplars across disciplines -- v. 4. Situational analysis : essentials and exemplars.
  • Digital
    Otto O. Yang.
    Digital : Springer2012
    Overview: overall goals when writing grant applications -- Organization and use of this guide -- Preparing to write -- Types of NIH grants -- Anatomy of the NIH grant application -- Starting to write: planning the aims and overcoming writer's block -- Organization and writing style -- Figures and tables -- Specific aims -- Research strategy: significance -- Research strategy: innovation -- Research strategy: approach -- Bibliography and references cited -- Use of appendices -- Collaborators and consultants -- Training and career development grants -- Administrative sections and submission process -- Scoring process -- Resubmitting an application -- Non-NIH grants -- Conclusions.
  • Digital
    Jamie D. Riggs, Northwestern University, Illinois; Trent L. Lalonde, University of Northern Colorado, Colorado.
    Digital : Cambridge2017
    The data sets -- The model-building process -- Constant variance response models -- Nonconstant variance response models -- Discrete, categorical response models -- Count response models -- Time-to-event response models -- Longitudinal response models -- Structural equation modeling -- Matching data to models.
  • Digital
    edited by Zili Sloboda and William J. Bukoski.
    Digital : Springer2006
    I: HISTORICAL OVERVIEW: The emerging science of drug abuse prevention / William J. Bukoski -- II: SOCIAL CONTEXTS OF PREVENTION: Effective mass media strategies for drug abuse prevention campaigns / Philip Palmgreen and Lewis Donohew -- Drug abuse prevention curricula in schools / Gilbert J. Botvin and Kenneth W. Griffin -- Dissemination of research-based family intervention for the prevention of substance abuse / Karol L. Kumpfer and Steve Adler -- Peers and the prevention of adolescent drug use -- / E. R. Oetting and R. S. Lynch -- Mobilizing communities to reduce risk for drug abuse: a comparison of two strategies / Michael W. Arthur, Charles D. Ayers, Kelly A. Graham, and J. David Hawkins -- Community-focused drug abuse prevention / Barry M. Kibel and Harold D.Holder -- Drug abuse prevention in the workplace / Royer F. Cook -- Prevention approaches to methadone treatment settings: children of drug abuse treatment clients / Richard F. Catalano, Kevin P. Haggerty, and Randy R. Gainey -- III: PREVENTION AS SOCIAL CONTROL: Drug tests in prevention research / Robert L. DuPont and Keith E. Saylor -- Anti-drug-abuse policies on prevention strategies / Mary Ann Pentz -- IV: THEORETICAL AND EMPIRICAL FOUNDATIONS OF PREVENTION: Forging a relationship between drug abuse epidemiology and drug abuse prevention / Zili Sloboda -- Risk and protective factors of adolescent drug use: implications for prevention programs / Judith S. Brook. David W. Brook, Linda Richter, and Martin Whiteman -- Bridging the gap between substance use prevention theory and practice / Brian R. Flay and John Petraitis -- Preventive intervention targeting precursors / John E. Lochman -- Designing prevention programs: the developmental perspective / Marvin W. Berkowitz and Audrey L. Begun -- V: SPECIAL POPULATIONS: Gender issues in substance abuse prevention / Louise Ann Rohrbach and Joel Milam -- Preventing substance use among Latino youth / Charles R. Martinez, Jr., J. Mark Eddy, and David S. DeGarmo -- African-American substance use epidemiology and prevention issues / William L. Turner and Michael J. Hench -- The effectiveness of alcohol and drug abuse prevention among American-Indian youth / Fred Beauvais and Joseph E. Trimble -- Drug abuse prevention research for Asian and Pacific Islander Americans / W. William Chen -- VI: INTERACTIONS BETWEEN BIOLOGY AND SOCIAL CONTEXT: RISKS FOR MULTIPLE BEHAVIORAL AND MENTAL DISORDERS: Basic science and drug abuse prevention: neuroscience, learning, and personality perspectives / Michael T. Bardo, Thomas Kelly, Donald R. Lynam, and Richard Milich -- Cross-national comparisons of co-morbidities between substance use disorders and mental disorders / Ronald C. Kessler, Sergio Aguilar-Gaxiola, Laura Andrade, Rob Bijl ... [et al.] -- Drug abuse research for high-risk youth / Leona L. Eggert and Brooke P. Randell -- Research designs for family studies / Michael Vanyukov, Howard Moss, and Ralph E. Tarter -- VII: RESEARCH DESIGN, MEASUREMENT, AND DATA ANALYTIC ISSUES: Design principles and their application in preventive field trials / C. Hendricks Brown -- Major data analysis issues in drug abuse prevention research / David P. MacKinnon and James H. Dwyer -- Metholological considerations to prevention research / Linda M. Collins and Brian P. Flaherty -- Prevention program implementation / Steven Schinke and Kristin Cole -- Family management practices: research design and measurement issues / Thomas J. Dishion, Bert Burraston, and Fuzhong Li -- Power analysis models and methods: a latent variable framework for power estimation and analysis / Terry E. Duncan, Susan C. Duncan, and Puzhong Li -- VIII: DRUG ABUSE PREVENTION: A LOOK TO THE FUTURE: Application of computer technology to drug abuse prevention / Kris Bosworth -- Putting science into practice / Gale Held.
  • Digital
    by Jean-Francois Denault.
    Digital : TandFonline2017
    Preface -- Introduction -- The market research basics -- Collecting data -- primary research -- Secondary research -- Analyzing data -- Estimates and models -- The look n' feel -- Final words -- Bibliography -- Index.
  • Digital
    edited by Carolyn D. Berdanier, Johanna T. Dwyer, David Heber.
    Digital : CRCnetBASE2014
    "Beginning with an overview of food and food constituents, the book outlines current nutrient analysis systems, techniques for data analysis, and food labeling. The book reviews nutrition science including terminology, biochemistry, nutrient-nutrient interactions, and comparative nutrition. There is a detailed assessment in section three on nutritional needs throughout the lifecycle. It highlights exercise and the value of vegetarian diets in health promotion and disease prevention. Section four considers issues surrounding nutritional assessment, screening, and monitoring tools including questionnaires, and anthropometric-, psychological-, and energy-assessments--Provided by publisher.
  • Digital
    Sandra L. Christenson, Amy L. Reschly, Cathy Wylie, editors.
    Digital : Springer2012
    pt. 1. What is student engagement? -- pt. 2. Engagement as linked to motivational variables -- pt. 3. Engagement and contextual influences -- pt. 4. Student engagement : determinants and student outcomes -- pt. 5. Measurement issues, instruments, and approaches.
  • Digital
    edited by Gertrude Hirsch Hadorn ... [et al.].
    Digital : Springer2008
  • Digital
    Longjian Liu.
    Digital : ScienceDirect2018
  • Digital
    Roger A. Pielke, Jr.
    Digital : Cambridge2007
    Relevant to a wide range of scientific disciplines, this is a practical guide for scientists, politicians and citizens to the relationship between science and politics.
  • Digital
    Markus K. Heinemann, MD, PhD, editor-in-chief.
    Digital : Thieme2016
    Writing a medical paper, or any other scientific text, is full of pitfalls which make it difficult to get it accepted for publication. This unique book gives practical advice on how one can circumvent these dangers. It is richly filled with examples, predominantly negative ones. which exhibit how one should not write a medical paper. This book highlights the fallibilities that manuscripts are often susceptible to, and hence will help writers avoid committing those mistakes. Special Features: Abundant information about a complex subject condensed in a small format Numerous examples from bad man.
  • Print
    Trisha Greenhalgh.
    Print2010
    Status: Not Checked OutLane Catalog Record
    Why read papers at all? -- Searching the literature -- Getting your bearings : what is this paper about? -- Assessing methodological quality -- Statistics for the non-statistician -- Papers that report trials of drug treatments and other simple interventions -- Papers that report trials of complex interventions -- Papers that report diagnostic or screening tests -- Papers that summarise other papers (systematic reviews and meta-analyses) -- Papers that tell you what to do (guidelines) -- Papers that tell you what things cost (economic analyses) -- Papers that go beyond numbers (qualitative research) -- Papers that report questionnaire research -- Papers that report quality improvement case studies -- Getting evidence into practice.
  • Digital
    Willo Pequegnat, Ellen Stover, Cheryl Anne Boyce, editors.
    Digital : Springer2011
    Grantsmanship : necessary but not sufficient strategies for success / Willo Pequegnat -- Community-based collaborations : designing, conducting and sustaining prevention programs / Mary M. McKay, Carl C. Bell, and Clair A. Blake -- Funding opportunity announcements / Jean Noronha -- Selecting the appropriate research mechanism : finding the right match / Cheryl Anne Boyce and Courtney Ferrell Aklin -- Selecting issues and hypotheses for a research proposal / Spero M. Manson -- Electronic submission process / Jean Noronha -- The review process / Anita Miller Sostek -- Common mistakes in proposal writing and how to avoid them / Susan Folkman and Willo Pequegnat -- Reading between the lines of your summary statement / William Lyman, Bonita Stanton, and Willo Pequegnat -- The award process / Ellen Stover -- So you were awarded your grant, now what? / Seth C. Kalichman -- Developing a theoretical framework and rationale for a research proposal / Gregory M. Herek -- How do you formulate a testable exciting hypothesis? / Robyn Dawes -- Qualitative inquiry : an end not just a means / Margaret E. Bentley, Elizabeth E. Tolley, and Willo Pequegnat -- Issues in assessment in research proposals / Helena Chmura Kraemer -- Using technology and the Internet in research / Joseph A. Konstan and William West -- Designing an intervention / Jose Szapocznik, Willo Pequegnat, and Guillermo Prado -- Designing an adequate control group / Thomas J. Coates -- Human subject protection and special population issues / Christine Moretto Wishnoff ... [et al.] -- Animal welfare and behavior / Kevin Quinn and Richard Nakamura -- Developing a resume and presenting your research team / Rayford Kytle and Cheryl Anne Boyce -- Writing the data analysis plan / A.T. Panter -- Developing a budget and financial justification / Masud Rahman -- Developing a quality control/quality assurance program / Lisa C. Strader and Willo Pequegnat -- Applying for training, career development, and early-stage research grants / Donna Mayo -- Cost-effectiveness : a key step in technology transfer / Steven D. Pinkerton and David R. Holtgrave -- Disseminating research findings to service providers and communities / Jeffrey A. Kelly -- Developing a plan for data sharing / Christine Bachrach and Michael Spittel.
  • Digital
    Bjorn Gustavii, Lund University Hospital, Sweden.
    Digital : Cambridge2017
  • Print
    Robert A. Day and Barbara Gastel.
    Print2011
    Status: Not Checked OutLane Catalog Record
    What is scientific writing? -- Historical perspectives -- Approaching a writing project -- What is a scientific paper? -- Ethics in scientific publishing -- Where to submit your manuscript -- How to prepare the title -- How to list the authors and addresses -- How to prepare the abstract -- How to write the introduction -- How to write the materials and methods section -- How to write the results -- How to write the discussion -- How to state the acknowledgments -- How to cite the references -- How to design effective tables -- How to prepare effective graphs -- How to prepare effective photographs -- Rights and permissions -- How to submit the manuscript -- The review process (how to deal with editors) -- The publishing process (how to deal with proofs) -- How to write a review paper -- How to write opinion (book reviews, editorials, and letters to the editor) -- How to write a book chapter or a book -- How to write for the public -- How to present a paper orally -- How to prepare a poster -- How to write a conference report -- Use and misuse of English -- Avoiding jargon -- How and when to use abbreviations -- Writing clearly across cultures and media -- How to write science in English as a foreign language -- How to write a thesis -- How to prepare a curriculum vitae -- How to prepare grant proposals and progress reports -- How to write a recommendation letter- and how to ask for one -- How to work with the media -- How to provide peer review -- How to seek a scientific-communication career -- Appendix 1. Selected journal title word abbreviations -- Appendix 2. Words and expressions to avoid -- Appendix 3. Prefixes and abbreviations for SI (système international) units -- Appendix 4. Some helpful websites -- Glossary of technical terms.
  • Digital
    Natalie Canavor and Claire Meirowitz.
    Digital : ProQuest Safari2010
    "This Element is an excerpt from 'The truth about the new rules of business writing' by Natalie Canavor and Claire Meirowitz. How to write successful proposals and grant applications"--Resource description page.
  • Digital
    Jan Schildmann...[et al.], editors.
    Digital : Springer2012
    Part 1. Historical and Socio-Cultural Contexts in Medical Research / British Responses to Nazi Medical War Crimes / Fiona McClenaghan -- History and its Relevance in the Development and Teaching of Research Ethics / Rael D. Strous -- Human Embryo Research and Islamic Bioethics: A View from Iran / Mansooreh Saniei -- From Farming to Pharming: Transcending of Bodily Existence as a Question of Medical Ethics in an Intercultural Context / Axel Siegemund -- Introduction / Jan Schildmann, Verena Sandow, Oliver Rauprich and Jochen Vollmann -- Part 2. Considerations on Ethical and Legal Regulations for Medical Research / Rethinking the Therapeutic Obligation in Clinical Research / Nunziata Comoretto -- Biomedical Research in Developing Countries and International Human Rights Law / Ilja R. Pavone -- Research Involving Human Subjects and Human Biological Material from a European Patent Law Perspective. Autonomy, Commodification, Patentability / Tomasz Zimny -- The Development and Validation of a Guide for Peruvian Research Ethics Committees to Assist in the Review of Ethical-Scientific Aspects of Clinical Trials / Susy Olave Quispe, Duilio Fuentes Delgado, Gabriela Minaya Martínez, Rosa Surco Ibarra and Martín Yagui Moscoso, et al. -- Part 3. Conflicts in Medical Research / Conflicts of Interest in Medical Research: What can Ethics Contribute? / Verena Sandow, Jan Schildmann and Jochen Vollmann -- Research Ethics in Genomics Research: Feedback of Individual Genetic Data to Research Participants / Annelien L. Bredenoord and Johannes J. M. van Delden -- Regulating "Higher Risk, No Direct Benefit" Studies with Children: Challenging the US Federal Regulations / Anna E. Westra, Jan M. Wit, Rám N. Sukhai and Inez D. de Beaufort -- Part 4. New Developments in Medical Research and Ethical Implications / A Paradigm Change in Research Ethics / Rieke van der Graaf and Johannes J. M. van Delden -- Translation of Cancer Molecular Biomarkers: Ethical and Epistemological Issues / Flavio D'Abramo and Cecilia Guastadisegni -- Rethinking the Ethics of Human Biomedical Non-Interventional Research / Kristi L{tilde}ouk.
  • Digital
    Digital : WHO2014
    Print2014
  • Digital
    edited by Victoria Stodden, Friedrich Leisch, Roger D. Peng.
    Digital : CRCnetBASE2014
    Part 1. Tools -- part 2. Practices and guidelines -- part 3. Platforms.
  • Print
    editor, Mukta M. Webber ; associate editor, Lea I. Sekely.
    Status: Not Checked OutLane Catalog Record
    v. 1. Carcinomas of the esophagus and colon.--v. 2. Carcinomas of the liver and pancreas.--v. 3. Carcinomas of the mammary gland, uterus, and skin.--v. 4. Carcinomas of the urinary bladder and kidney.--v. 5. Carcinoma of the prostate and testis.
  • Digital
    Leon S. Robertson.
    Digital : ProQuest Ebook Central2007
    Print2007
    Injury and the role of epidemiology -- Energy characteristics and control strategies -- Research objectives and usable data -- Injury severity -- Injury statistics -- National injury surveillance -- Local injury surveillance -- The use and abuse of causal analysis -- Research designs and data analysis -- Human factors -- Evaluation of programs to change human factors voluntarily -- Evaluation of laws and regulations directed at individual behavior -- Evaluation of agent, vehicle and environmental modifications -- Evaluation of post-injury treatment and rehabilitation -- Injury epidemiology and economics -- Summation of principles.
  • Digital
    [Institut National de la Santé et de la Recherche Médicale].
    Digital : NCBI Bookshelf2000-
    A collection of syntheses of the international scientific literature and recommendations on public health problems, by Inserm's expert advisory groups.
  • Digital
    Ülo Maiväli, University of Tartu, Institute of Technology.
    Digital : ScienceDirect2015
  • Digital
    edited by Ding-Geng Chen, Jianguo Sun, Karl E. Peace.
    Digital : CRCnetBASE2013
    "Preface The aim of this book is to present in a single volume an overview and latest developments in time-to-event interval-censored methods along with application of such methods. The book is divided into three parts. Part I provides an introduction and overview of time-to-event methods for interval-censored data. Methodology is presented in Part II. Applications and related software appear in Part III. Part I consists of two chapters. In Chapter 1, Sun and Li present an overview of recent developments, with attention to nonparametric estimation and comparison of survival functions, regression analysis, analysis of multivariate clustered- and analysis of competing risks interval-censored data. In Chapter 2, Yu and Hsu provide a review of models for interval-censored (IC) data, including: independent interval censorship models, the full likelihood model, various models for C1, C2, and MIC data as well as multivariate IC models. Part II consists of seven chapters (3-9). Chapters 3, 4 and 5 deal with interval-censored methods for current status data. In Chapter 3, Banerjee presents: likelihood based inference, more general forms of interval censoring, competing risks, smoothed estimators, inference on a grid, outcome misclassi- cation, and semiparametric models. In Chapter 4, Zhang presents regression analyses using the proportional hazards model, the proportional odds model, and a linear transformation model, as well as considering bivariate current status data with the proportional odds model. In Chapter 5, Kim, Kim, Nam and Kim develop statistical analysis methods for dependent current status data and utilize the R Package CSD to analyze such data"-- Provided by publisher.
  • Print
    edited by J. Dennis Blessing, J. Glenn Forister.
    Print2013
    Status: Not Checked OutLane Catalog Record
    Introduction -- Essays on research in the health professions -- Ethics in research -- Regulatory protection of human subjects in research -- Funding the research : grants -- The research problem -- Review of the literature -- Methodology -- Clinical investigations -- Survey research -- The clinical review -- Qualitative research -- Community-based participatory research -- Data analysis -- Results -- Discussion -- References -- What to do with what you have -- Writing and publishing in the health professions -- Interpreting the literature.
  • Digital
    [edited by] Professor P.M. Shaughn O'Brien, Professor Fiona Broughton-Pipkin.
    Digital : Cambridge2017
    "Research for the academic or clinical trainee may often be seen as a stepping stone for progression of career, enhancement of the curriculum vitae and fulfilment of curriculum competencies. However, research does teach a number of essential skills such as concentration and focus, in depth knowledge acquisition, team work, communication skills, patience, self-criticism and evaluation. All of these skills are transferrable and invariably important in the development of a competent clinician. Furthermore, the application of research skills is invaluable in the now common practice of developing and using evidence based medicine. Research performed which culminates in a further degree, publications and/or presentations show that a trainee has developed these skills to a satisfactory level and showcase these to a future employer. In summary, research experience for the specialist trainee is extremely important in the current medical environment and depending on individual circumstances the training pathway has evolved to facilitate as much exposure as desired. The chapters in this book expand on this introduction and will provide valuable support and a source of inspiration for both academic and clinical trainees"--Provided by publisher.
  • Digital
    Kathleen F. Weaver [and four others].
    Digital : Wiley2017
  • Digital
    Pentti Rautaharju and Farida Rautaharju.
    Digital : Springer2007
  • Digital
    Ronald R. Gauch.
    Digital : Springer2009
  • Digital
    J. Rick Turner.
    Digital : Springer2012
  • Digital
    Thanos Athanasiou, Haile Debas, Ara Darzi (eds.).
    Digital : Springer2010
  • Digital
    Michael Bloor and Fiona Wood.
    Digital : SAGE2006
    A practical guide to qualitative techniques for students and researchers across the social and health sciences, this work provides coverage of qualitative methods complemented by extended illustration from the array of academic disciplines in which qualitative research is found and employed.
  • Digital
    Oliver Gassmann, Gerrit Reepmeyer, Maximilian von Zedtwitz.
    Digital : Springer2008
  • Digital
    [Panel on IRBs, Surveys and Social Science Research, Cora Marrett, chair].
    Digital : NAP2002
  • Digital
    editors, Rakesh Srivastava, Wojciech Maksymowicz, Wlodek Lopaczynski.
    Digital : WorldScientific2014
    This book is all about the definition and finding ways to prioritize and accelerate translation research in biomedical sciences and rapidly turning new knowledge into first-in-human studies. It represents an effort to bring together scientists active in various areas of translational research to share science and, hopefully, generate new ideas and potential collaborations. The book provides a comprehensive overview of translational work that includes significant discoveries and pioneering contributions, e.g., in immunology, gene therapy, stem cells and population sciences. It may be used as an advanced textbook by graduate students and even ambitious undergraduates in biomedical sciences. It is also suitable for non-experts, i.e. medical doctors, who wish to have an overview of some of the fundamental models in translational research. Managing the translational enterprise remains a work in progress. The world is changing rapidly, and the scientific world needs to seek new ways to ensure that discoveries get translated for patients efficiently and as quickly as possible. In addition, everyone expects the investment in biomedical research should pay dividends through effective therapeutic solutions. This unique project provides a broad collaborative approach of the international scientific team to present its view and opinion how to cross barriers to incentives for translational research in medical sciences. Contributing to the book is an international team of prominent co-authors. The book consists of unique and widely treated topics, and includes new hypotheses, data and analyses.
  • Print
    S. Lochlann Jain.
    Print2013
    Status: Not Checked OutLane Catalog Record
    "Cancer can kill: this fact makes it concrete. Still, it's a devious knave. Nearly every American will experience it up-close and all too personally, wondering why the billions of research dollars thrown at the word haven't exterminated it from the English language. Like a sapper diffusing a bomb, Jain unscrambles the emotional, bureaucratic, medical, and scientific tropes that create the thing we call cancer. Scientists debate even the most basic facts about the disease, while endlessly generated, disputed, population data produce the appearance of knowledge. Jain takes the vacuum at the center of cancer seriously and demonstrates the need to understand cancer as a set of relationships--economic, sentimental, medical, personal, ethical, institutional, statistical. Malignant analyzes the peculiar authority of the socio-sexual psychopathologies of body parts; the uneven effects of expertise and power; the potentially cancerous consequences of medical procedures such as IVF; the huge industrial investments that manifest themselves as bone-cold testing rooms; the legal mess of medical malpractice law; and the teeth-grittingly jovial efforts to smear makeup and wigs over the whole messy problem of bodies spiraling into pain and decay. Malignant examines the painful cognitive dissonances produced by the ways a culture that has relished dazzling success in every conceivable arena have twisted one of its staunchest failures into an economic triumph. The intractable foil to American achievement, cancer hands us -- on a silver platter and ready for Jain's incisively original dissection -- our sacrifice to the American Dream"-- Provided by publisher.
  • Digital
    Peter J. Snyder, Linda C. Mayes, William E. Smith.
    Digital : ScienceDirect2015
    The Management of Scientific Integrity within Academic Medical Centers discusses the impact scientific misconduct has in eight complex case studies. Authors look at multifaceted mixtures of improper behavior, poor communication, cultural issues, adverse medical/health issues, interpersonal problems and misunderstandings to illustrate the challenge of identifying and managing what went wrong and how current policies have led to the establishment of quasi legal processes within academic institutions. The book reviews the current global regulations and concludes with a section authored by a US federal court judge who provides his perspective on the adequacy of current regulations and policies.
  • Digital
    Silvia M. Rogers.
    Digital : Springer2007
  • Digital
    by Silvia M. Rogers.
    Digital : Springer2014
    This self-help guide is intended for scientists and medical professionals and students who wish to improve their scientific writing skills. Exercises invite the reader to practice the most important aspects of scientific writing. Although the book addresses certain issues more troublesome to scientific communicators of a non-English language origin, the guide will be of equal benefit to those whose first language is English. If you want not only to write but to write well, this book is for you. This second edition takes into account new developments in the area of scientific communication. In particular, the importance of authenticity is addressed, drawing attention to the sensitive issue of plagiarism in scientific texts.
  • Digital
    Mohamed M. Shoukri.
    Digital : CRCnetBASE2011
    "Emphasizing applications over theory, this book provides a comprehensive survey of this method and provides readers with standards and directions on how to run sound clinical and other types of studies. The author clearly explains how to reduce measurement error and presents numerous practical examples of the interobserver agreement approach. To help with problem solving, he includes SAS code, both within the book and on the CRC website. An extensive review of the literature offers access to the latest developments in the field. This edition presents new applications, new tables, more detail on SAS, new code, updated references, and two new chapters"--Provided by publisher.
  • Digital
    [edited by] Theodore R. Kucklick.
    Digital2006Click LINK above for Print location/circulation status.
    Digital : CRCnetBASE2006
  • Digital
    Digital : WHO2010
    Print2010
  • Digital
    Charles Fried ; edited by Franklin Miller and Alan Wertheimer.
    Digital : Oxford Medicine Online2016
    This new edition of Charles Fried's Medical Experimentation includes a general introduction by Franklin Miller and the late Alan Wertheimer, a reprint of the 1974 text, an in-depth analysis by Harvard Law School scholars I. Glenn Cohen and D. James Greiner, and a new essay by Fried reflecting on the original text and how it applies to the contemporary landscape of medicine and medical experimentation.
  • Digital
    Robert B. Taylor.
    Digital : Springer2011
    Getting Started in Medical Writing -- Basic Writing Skills -- From Page One to the End -- Technical Issues in Medical Writing -- What's Special About Medical Writing? -- How to Write a Review Article -- Case Reports, Editorials, Letters to the Editor, Book Reviews, and Other Publication Models -- Writing Book Chapters and Books -- How to Write a Research Protocol -- How to Write a Grant Proposal -- How to Write a Report of a Clinical Study -- Getting Your Writing Published.
  • Digital
    David A. Schwartz, editor.
    Digital : Springer2011
    Physician-scientists are unusual creatures. While we are drawn to the clinical challenges of our patients, we are also drawn to the opportunities that our patients' medical problems bring to science. This book contains the unique experiences and encounters that drew 21 accomplished physician-scientists to this profession. These personal stories are those of people and circumstances that have had profound effects on our career decisions, our creative opportunities, and our lives. These stories also serve to highlight the lessons learned along the way and the distinct attributes of these women and men of medicine and science. Our combined hope is that our collective biographies will enhance the public understanding of our profession, will move people from medicine to science and from science to medicine, and will inspire those who are contemplating this extraordinary profession.
  • Digital
    Mallikarjun B. Hanji.
    Digital : CRCnetBASE2017
    Protocol writing for meta-analysis study -- Formulation of research problem -- Location and selection of studies -- Quality assessment of selected studies -- Effect sizes of primary studies -- Preparation of meta-analysis master sheet -- Meta-analysis plots -- Meta-analysis of two studies -- Methods for pooling estimates : fixed effects mode -- Method for pooling estimates : random effects model -- Individual patient data meta-analysis -- Meta-analysis of observational studies -- Additional meta-analysis techniques -- Reporting meta-analysis results -- Implications of results of meta-analysis -- Meta-analysis software -- Running meta-analysis using STATA.
  • Digital
    Dankmar Böhning, Ronny Kuhnert, Sasivimol Rattanasiri.
    Digital : CRCnetBASE2008
  • Digital
    edited by N. Balakrishnan.
    Digital : Wiley2014
  • Digital
    edited by N. Balakrishnan.
    Digital : Wiley2014
  • Print
    Dorfman, Ralph I.
    Status: Not Checked OutLane Catalog Record
    v. 1. Chemical determinations -- v. 2. Bioassay -- v. 3. & 4. Steroidal activity in experimental animals and man, Part A & B.
  • Digital
    William C.S. Cho, editor.
    Digital : Springer2011
    1 -- MicroRNAs in Cancer (An Overview) -- 2. The Role of MicroRNAs in Lung Cancer Development, Progression, and Metastasis -- 3. MicroRNAs in Breast Cancer -- 4. MicroRNAs in Colorectal Cancer -- 5. MicroRNAs in Gastric Cancer -- 6. MicroRNAs in Prostate Cancer: A Possible Role as Novel Biomarkers and Therapeutic Targets?- 7. MicroRNAs in Hepatocellular Carcinoma -- 8. MicroRNAs in Cervical Carcinoma -- 9. MicroRNAs in Esophageal Cancer -- 10. MicroRNAs in Bladder Cancer -- 11. MicroRNAs in Lymphoma -- 12. MicroRNAs in Leukemia -- 13. MicroRNAs in Pancreatic Cancer: Potential Interests as Biomarkers and Therapeutic Tools -- 14. MicroRNAs in Epithelial Ovarian Cancer -- 15. MicroRNAs in Brain Tumors -- 16. MicroRNAs and Cancer Stem Cells -- 17. MicroRNAs in Cancer Invasion and Metastasis -- 18. MicroRNAs in Predicting Radiotherapy and Chemotherapy Response -- 19. Role of MicroRNAs in Anti-cancer Drug Resistance -- 20. MicroRNAs and Cancer Metabolism -- 21. MicroRNAs as Blood-based Biomarkers of Cancer -- 22. RNAi-based Approaches to the Treatment of Brain Tumors.
  • Digital
    Digital2011
  • Digital
    edited by L.A. Reynolds and E.M. Tansey.
    Digital : Wellcome Trust2003
    "This transcript considers the origins and impact of the MRC Applied Psychology Unit's work from 1944 to 1998."
  • Digital
    edited by Ray Paton and Laura A. McNamara.
    Digital : ScienceDirect2006
  • Digital
    James R. Carpenter, Michael G. Kenward.
    Digital : Wiley2013
    Introduction -- The multiple imputation procedure and its justification -- Multiple imputation of quantitative data -- Multiple imputation of binary and ordinal data -- Multiple imputation of unordered categorical data -- Nonlinear relationships -- Interactions -- Survival data, skips and large datasets -- Multilevel multiple imputation -- Sensitivity analysis: MI unleashed -- Including survey weights -- Robust multiple imputation.
  • Digital
    edited by Alex Dmitrienko, Ajit C. Tamhane, Frank Bretz.
    Digital : CRCnetBASE2010
    1. Multiplicity problems in clinical trials : a regulatory perspective / Mohammad Huque and Joachim Rèohmel -- 2. Multiple testing methodology / Alex Dmitrienko ... [et al.] -- 3. Multiple testing in dose-response problems / Frank Bretz, Ajit C. Tamhane, and Josâe Pinheiro -- 4. Analysis of multiple endpoints in clinical trials / Ajit C. Tamhane and Alex Dmitrienko -- 5. Gatekeeping procedures in clinical trials / Alex Dmitrienko and Ajit C. Tamhane -- 6. Adaptive designs and confirmatory hypothesis testing / Willi Maurer, Michael Branson, and Martin Posch -- 7. Design and analysis of microarray experiments for pharmacogenomics / Jason C. Hsu ... [et al.].
  • Digital
    Damon M. Berridge, Robert Crouchley.
    Digital : CRCnetBASE2011
    Machine generated contents note: 2.1. Introduction -- 2.2. Continuous/interval scale data -- 2.3. Simple and multiple linear regression models -- 2.4. Checking assumptions in linear regression models -- 2.5. Likelihood: multiple linear regression -- 2.6. Comparing model likelihoods -- 2.7. Application of a multiple linear regression model -- 2.8. Exercises on linear models -- 3.1. Binary data -- 3.1.1. Introduction -- 3.1.2. Logistic regression -- 3.1.3. Logit and probit transformations -- 3.1.4. General logistic regression -- 3.1.5. Likelihood -- 3.1.6. Example with binary data -- 3.2. Ordinal data -- 3.2.1. Introduction -- 3.2.2. The ordered logit model -- 3.2.3. Dichotomization of ordered categories -- 3.2.4. Likelihood -- 3.2.5. Example with ordered data -- 3.3. Count data -- 3.3.1. Introduction -- 3.3.2. Poisson regression models -- 3.3.3. Likelihood -- 3.3.4. Example with count data -- 3.4. Exercises -- 4.1. Introduction -- 4.2. The linear model 4.3. The binary response model -- 4.4. The Poisson model -- 4.5. Likelihood -- 5.1. Introduction -- 5.2. Linear mixed model -- 5.3. The intraclass correlation coefficient -- 5.4. Parameter estimation by maximum likelihood -- 5.5. Regression with level-two effects -- 5.6. Two-level random intercept models -- 5.7. General two-level models including random intercepts -- 5.8. Likelihood -- 5.9. Residuals -- 5.10. Checking assumptions in mixed models -- 5.11. Comparing model likelihoods -- 5.12. Application of a two-level linear model -- 5.13. Two-level growth models -- 5.13.1. A two-level repeated measures model -- 5.13.2. A linear growth model -- 5.13.3. A quadratic growth model -- 5.14. Likelihood -- 5.15. Example using linear growth models -- 5.16. Exercises using mixed models for continuous/interval scale data -- 6.1. Introduction -- 6.2. The two-level logistic model -- 6.3. General two-level logistic models -- 6.4. Intraclass correlation coefficient -- 6.5. Likelihood -- 6.6. Example using binary data -- 6.7. Exercises using mixed models for binary data 7.1. Introduction -- 7.2. The two-level ordered logit model -- 7.3. Likelihood -- 7.4. Example using mixed models for ordered data -- 7.5. Exercises using mixed models for ordinal data -- 8.1. Introduction -- 8.2. The two-level Poisson model -- 8.3. Likelihood -- 8.4. Example using mixed models for count data -- 8.5. Exercises using mixed models for count data -- 9.1. Introduction -- 9.2. The mixed linear model -- 9.3. The mixed binary response model -- 9.4. The mixed Poisson model -- 9.5. Likelihood -- 10.1. Introduction -- 10.2. Three-level random intercept models -- 10.3. Three-level generalized linear models -- 10.4. Linear models -- 10.5. Binary response models -- 10.6. Likelihood -- 10.7. Example using three-level generalized linear models -- 10.8. Exercises using three-level generalized linear mixed models -- 11.1. Introduction -- 11.2. Multivariate two-level generalized linear model -- 11.3. Bivariate Poisson model: example -- 11.4. Bivariate ordered response model: example -- 11.5. Bivariate linear-probit model: example -- 11.6. Multivariate two-level generalized linear model likelihood 11.7. Exercises using multivariate generalized linear mixed models -- 12.1. Introduction -- 12.1.1. Left censoring -- 12.1.2. Right censoring -- 12.1.3. Time-varying explanatory variables -- 12.1.4. Competing risks -- 12.2. Duration data in discrete time -- 12.2.1. Single-level models for duration data -- 12.2.2. Two-level models for duration data -- 12.2.3. Three-level models for duration data -- 12.3. Renewal data -- 12.3.1. Introduction -- 12.3.2. Example: renewal models -- 12.4. Competing risk data -- 12.4.1. Introduction -- 12.4.2. Likelihood -- 12.4.3. Example: competing risk data -- 12.5. Exercises using renewal and competing risks models -- 13.1. Introduction -- 13.2. Mover-stayer model -- 13.3. Likelihood incorporating the mover-stayer model -- 13.4. Example 1: stayers within count data -- 13.5. Example 2: stayers within binary data -- 13.6. Exercises: stayers -- 14.1. Introduction to key issues: heterogeneity, state dependence and non-stationarity -- 14.2. Example -- 14.3. Random effects models -- 14.4. Initial conditions problem -- 14.5. Initial treatment 14.6. Example: depression data -- 14.7. Classical conditional analysis -- 14.8. Classical conditional model: example -- 14.9. Conditioning on initial response but allowing random effect uol to be dependent on z3 -- 14.10. Wooldridge conditional model: example -- 14.11. Modelling the initial conditions -- 14.12. Same random effect in the initial response and subsequent response models with a common scale parameter -- 14.13. Joint analysis with a common random effect: example -- 14.14. Same random effect in models of the initial response and subsequent responses but with different scale parameters -- 14.15. Joint analysis with a common random effect (different scale parameters): example -- 14.16. Different random effects in models of the initial response and subsequent responses -- 14.17. Different random effects: example -- 14.18. Embedding the Wooldridge approach in joint models for the initial response and subsequent responses -- 14.19. Joint model incorporating the Wooldridge approach: example -- 14.20. Other link functions -- 14.21. Exercises using models incorporating initial conditions/state dependence in binary data 15.1. Introduction -- 15.2. Fixed effects treatment of the two-level linear model -- 15.3. Dummy variable specification of the fixed effects model -- 15.4. Empirical comparison of two-level fixed effects and random effects estimators -- 15.5. Implicit fixed effects estimator -- 15.6. Random effects models -- 15.7. Comparing two-level fixed effects and random effects models -- 15.8. Fixed effects treatment of the three-level linear model -- 15.9. Exercises comparing fixed effects and random effects -- A.1. SabreR installation -- A.2. SabreR commands -- A.2.1. The arguments of the SabreR object -- A.2.2. The anatomy of a SabreR command file -- A.3. Quadrature -- A.3.1. Standard Gaussian quadrature -- A.3.2. Performance of Gaussian quadrature -- A.3.3. Adaptive quadrature -- A.4. Estimation -- A.4.1. Maximizing the log likelihood of random effects models -- A.5. Fixed effects linear models -- A.6. Endogenous and exogenous variables -- B.1. Getting started with R -- B.1.1. Preliminaries -- B.1.1.1. Working with R in interactive mode -- B.1.1.2. Basic functions -- B.1.1.3. Getting help B.1.1.4. Stopping R -- B.1.2. Creating and manipulating data -- B.1.2.1. Vectors and lists -- B.1.2.2. Vectors -- B.1.2.3. Vector operations -- B.1.2.4. Lists -- B.1.2.5. Data frames -- B.1.3. Session management -- B.1.3.1. Managing objects -- B.1.3.2. Attaching and detaching objects -- B.1.3.3. Serialization -- B.1.3.4. R scripts -- B.1.3.5. Batch processing -- B.1.4. R packages -- B.1.4.1. Loading a package into R -- B.1.4.2. Installing a package for use in R -- B.1.4.3. R and Statistics -- B.2. Data preparation for SabreR -- B.2.1. Creation of dummy variables -- B.2.2. Missing values -- B.2.3. Creating lagged response covariate data.
  • Digital
    Committee on Cancer Clinical Trials and the NCI Cooperative Group Program, Board on Health Care Services.
    Digital : NAP2010
    Introduction -- The science of developing cancer therapy -- Operations, oversight, and funding of cancer clinical trials -- Physician and patient participation in cancer clinical trials.
  • Digital
    Mary Moran, Nick Chapman, Lisette Abela-Oversteegen, Vipul Chowdhary, Anna Doubell, Christine Whittall, Rachel Howard, Penny Farrell, Dale Halliday, Catherine Hirst.
    Digital2015
    In 2014, a reported $3,377m was invested in neglected disease R&D, consisting of $3,197m from repeat survey participants (called year-on-year -- YOY -- funders) and $179m from irregular survey participants. Total YOY funding for neglected disease R&D increased by $150m (up 4.9%), but this was entirely the result of significant new investment in Ebola R&D in response to the 2014 West African Ebola epidemic. Without Ebola, YOY funding for neglected disease R&D would have been essentially unchanged from 2013 (down $14m, -0.4%).
  • Digital
    Jill Scott, Esther Stoeckli, editors.
    Digital : Springer2012
    Neural Development -- Visual Perception -- Tactile Perception -- Skin And Environment -- Conclusion: Neuromedia: Talking into the Future.
  • Digital
    Ben Shneiderman.
    Digital : OSO2016
    Part I. Guiding principles. -- 1. Combining applied and basic research : the ABC principle -- 2. Blending science, engineering, and design : the SED principle -- Part II. Science, engineering, and design. -- 3. What science contributes : persistence in understanding the world -- 4. What engineering contributes : devotion to innovative technologies -- 5. What design contributes : fresh thinking to serve human needs -- Part III. Research life cycle strategies. -- 6. Choose actionable problems that address civic, business, and global priorities -- 7. Apply observation, intervention, and controlled experiments -- 8. Form teams with diverse individuals and organizations -- 9. Test ideas and prototypes with realistic interventions -- 10. Promote adoption and assess impact -- Part IV. Making it happen. -- 11. Recommendations for action -- 12. Change is hard, but possible.
  • Digital
    [Harold Varmus], Office of Director, National Institutes of Health.
    Digital : NIH1999
  • Digital
    National Institutes of Health.
    Digital : NIH2001-
  • Digital
    Pei He.
    Digital2012
    In clinical trials, enrolled patients are randomized into treatment and control groups to test if the new treatment has advantages over the control. Data have been collected from both groups to form test statistics. For life-threatening diseases, such as cancer and heart attacks, the primary endpoint of a confirmatory trial for a new treatment is time to failure. This endpoint often involves censored data because some subjects may not fail by the end of the study or may have been lost to follow-up. To handle survival data in the problem of explanatory variables, Cox (1972) introduced a semi-parametric model based on the assumption of proportional hazards. In this model, the log ratio of the hazard function of the treatment group to that of the control group is a constant that does not vary over time. Earlier Mantel (1966) introduced the logrank test that is asymptotically efficient for proportional hazards alternative. Both logrank test and proportional hazards regression model have become standard procedures in clinical trials with survival endpoints. Since clinical trials can run for years, interim analyses by a Data and Safety Monitoring Board (DSMB) are typically included in the trial protocol. This led to the development of "time-sequential'' methods for early stopping during interim analyses. Lan and DeMets (1988) have noted that there are two time scales in time-sequential trials. One is the calendar time t at which interim analysis is carried out, and the other is the information time V(t), which can be measured by the variance of the test statistic (under the null hypothesis) based on all the data collected up to time t and is unknown before time t. Therefore, to determine the sample size and study duration, assumptions have to be made on the accrual rate, the survival distribution of both treatment and control groups, and the censoring distribution. These assumptions are commonly based on the literature concerning related studies and on educated guesses. In particular, since logrank tests and time-invariant hazard ratios are typically used to summarize the results of the studies, it is convenient to assume proportional hazards as the working model at the design stage. During interim analyses, marked discrepancies for the assumptions at the design stage may be observed. Herein we propose a group sequential design that addresses theses discrepancies and thereby makes the trial more efficient in terms of power, study duration and expected sample size. The design allows one to combine the logrank statistic with the more powerful test statistics in case of non-proportional hazards at the terminal stage. A new approach to futility stopping is developed as well as a piecewise constant hazard ratio model replacing the proportional hazards model.
  • Digital
    Minoru Onozuka, Chen-Tung Yen, editors.
    Digital : Springer2008
  • Digital
    Geri LoBiondo-Wood, PhD, RN, FAAN, Professor and Coordinator, PhD in Nursing Program, University of Texas Health Science Center at Houston, School of Nursing, Houston, Texas, Judith Haber, PhD, APRN, BC, FAAN, the Ursula Springer Leadership Professor in Nursing, Associate Dean for Graduate Programs, New York University, College of Nursing, New York, New York.
    Digital : ProQuest Ebook Central2014Limited to 3 simultaneous users
    Now in full color, this easy-to-understand textbook offers a comprehensive introduction to nursing research concepts and methods. Evidence-based practice is emphasized throughout, with clear guidelines for evaluating research and applying scientific evidence to practice.
  • Digital
    William C.S. Cho, editor.
    Digital : Springer2010
  • Digital
    Gustavo Duque, Ken Watanabe (editors).
    Digital : Springer2011
    How to Select Your Animal Model for Osteoporosis Research / A. Simon Turner -- Skeletal Phenotyping in Rodents: Tissue Isolation and Manipulation / Janet E. Henderson, Chan Gao and Edward J. Harvey -- Methods in Bone Biology in Animals: Biomechanics / José B. Volpon and Antonio C. Shimano -- Methods in Bone Histomorphometry for Animal Models / Natalie Dion, Audray Fortin and Louis-Georges Ste-Marie -- Methods in Bone Biology in Animals: Imaging / Blaine A. Christiansen and Mary L. Bouxsein -- Methods in Bone Biology in Animals: Biochemical Markers / Markus Herrmann -- Methods in Bone Biology: Cancer and Bone / Yu Zheng, Markus J. Seibel and Hong Zhou -- How to Test Osteoporosis Treatments in Experimental Animals / Robert J. van ʻt Hof -- The Ovariectomized Mice and Rats / Jameela Banu -- Classical Models of Senile Osteoporosis / Ken Watanabe -- Animal Models of Premature Aging / Wei Li and Gustavo Duque -- Nonhuman Primate Models of Osteoporosis / Susan Y. Smith, Aurore Varela and Jacquelin Jolette -- Other Large Animal Models / Susan Reinwald and David B. Burr -- Mouse models for the Study of Fracture Healing and Bone Regeneration / Joerg H. Holstein, Patric Garcia, Tina Histing, Moritz Klein and Steven C. Becker, et al.
  • Digital
    edited by H.C.G. Matthew and Brian Harrison.
  • Digital
    Includes all of words, phrases, and translations, in French, German, Spanish and Italian from the print dictionaries. Users can search the full A-Z from both sides of the dictionary in Oxford's unabridged bilingual dictionaries: French, German, Spanish, and Italian.
  • Digital
    edited by Tony Kennedy.
    Digital : CRCnetBASE2008
    Digital : ProQuest Ebook Central2008
    Print2008
    Strategic project management at the project level / Tony Kennedy -- Strategic project management at the portfolio level / Kevin Bilyard and Des Markland -- Project planning : from basic concepts to systems application / Carl A. Kutzbach, Carole Strong, and Sylvia Walker -- Project management of chemical, analytical, and formulation development / Dieter Krimmer -- Project management in exclusive synthesis / Lukas M.J. von Hippel -- Clinical trials--can they be project managed? / Les Rose -- Regulatory project management / Nicholas Wells -- Teams / Ralph White -- Project management and outsourcing drug development / Jon Court and Mark Fowler -- The project management function / Tony Kennedy.
  • Digital
    Mark J. Eisenberg.
    Digital : Springer2011
    pt. 1. Getting started as physician-scientist. -- Beginnings -- Is a physician-scientist career right for you? -- Training as a physician-scientist -- pt. 2. Launching your career as a physician-scientist. -- Getting a job -- Appointments, tenure, promotions, and sabbaticals -- Teaching -- Administration -- Research -- pt. 3. Building your career as a physician-scientist. -- Writing -- Publishing -- Grants -- Grantsmanship -- Peer review of grant applications -- Managing your team, time, and money -- Mentorship -- Lectures and presentations -- Relations with industry -- pt. 4. Parting words of advice : putting it all together. -- Balancing research, clinical activities, and family life -- Improving the physician-scientist pathway -- Concluding remarks.
  • Digital
    Robert A. Parker, Harvard Medical School, Nancy Greene Berman, School of Public Health, UCLA Los Angeles.
    Digital : Cambridge2016
  • Digital
    edited by Zdenko Machala, Karol Hensel, and Yuri Akishev.
    Digital : Springer2012
  • Print
    collected by the Engineering foundation, New York, Jan. l5, 1921.
    Print1924-
    Status: Not Checked OutLane Catalog Record
  • Digital
    edited by A.R. Ness, L.A. Reynolds, E.M. Tansey.
    Digital : Wellcome2002
  • Digital
    Berryman, A. A.; Berryman, A. A.; Kindlmann, Pavel.
    Digital : Springer2008
  • Digital
    Andrew D. Hollenbach, Ph.D., Associate Professor of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA.
    Digital : ScienceDirect2014
  • Print
    [edited by] John I. Gallin, Frederick P. Ognibene.
    Print2007
    Status: Not Checked OutLane Catalog Record
  • Digital
    edited by John Gallin, Frederick P. Ognibene.
    Digital : ScienceDirect2012
    This expanded third edition provides an introduction to the conduct of clinical research as well as more comprehensive and expansive content about the infrastructure necessary for a successful clinical research organization or enterprise. With authors who are experts in clinical research in both the public and private sectors, this publication provides essential information to clinical investigators who wish to develop and conduct well designed patient-based research protocols that comply with rigorous study design, ethical, and regulatory requirements.
  • Digital
    edited by Manuel Hidalgo, S. Gail Eckhardt, Elizabeth Garrett-Mayer, Neil J. Clendeninn.
    Digital : Springer2011
    Basic biostatistics for the clinical trialist / Elizabeth G. Hill and Elizabeth Garrett-Mayer -- Fundamental concepts in clinical pharmacology / Daniel L. Gustafson and Erica L. Bradshaw-Pierce -- Bioanalycial methods in clinical drug development / Walter J. Loos, Peter de Bruijn and Alex Sparreboom -- Preclinical models for anticancer drug development / Edward A. Sausville -- Phase I clinical trials with anticancer agents / Stephen Leong ... [et al.] -- Phase II trials with anticancer agents / Hui K. Gan, J. Jack Lee and Lillian L. Siu -- Phase III clinical trials with anticancer agents / Wendy R. Parulekar and Daniel J. Sargent -- Pharmacokinetic studies in early anticancer drug development / Alex Sparreboom and Sharyn D. Baker -- Pharmacodynamic studies in early phase drug development / D. Ross Camidge, Robert C. Doebele and Antonio Jimeno -- Prediction of antitumor response / Fred R. Hirsch and Yu Shyr -- Imaging studies in anticancer drug development / David A. Mankoff -- Role of the U.S. Food and Drug Administration in cancer drug development / Ann T. Farrell, Ramzi N. Dagher and Richard Pazdur -- Early clinical trials with cytotoxic agents / M.J.A. de Jonge and Jaap Verweij -- Challenges and successes in developing effective anti-angiogenic agents / Laura Q.M. Chow and S. Gail Eckhardt -- Targeted therapeutics in cancer treatment / Colin D. Weekes and Manuel Hidalgo -- Cancer chemoprevention / Christopher H. Lieu, William N. William Jr. and Scott Lippman -- Combined modality therapy in cancer management / David Raben and Kyle Rusthoven -- Cancer vaccines / Daniel Laheru -- Optimising the development of antibodies as treatment for cancer / Craig P. Carden, Hendrik-Tobias Arkenau and Johann S. de Bono -- Oligonucleotide therapeutics / Cy A. Stein, Britta Hoehn and John Rossi -- Anticancer drug development in pediatric patients / Lia Gore and Margaret Macy -- Clinical trials in special populations / S. Percy Ivy ... [et al.] -- NCI-sponsored clinical trials / Andriana Papaconstantinou and Janet E. Dancey.
  • Digital
    Phyllis G. Supino, Jeffrey S. Borer, editors ; foreword by Stephen E. Epstein.
    Digital : Springer2012
  • Print
    edited by Martin Wehling ; foreword by Francesco M. Marincola.
    Print2010
    Status: Not Checked OutLane Catalog Record
    Introduction and definitions -- Target identification and validation -- Biomarkers -- Early clinical trial design -- Pharmaceutical toxicology -- Translational science biostatistics -- Learning by experience : examples of translational processes in the cardiovascular field.
  • Digital
    edited by Martin Wehling, Department of Clinical Pharmacology Mannheim, University of Heidelberg, Mannheim, Germany.
    Digital : ScienceDirect2015
    Principles of Translational Science in Medicine: From Bench to Bedside, Second Edition, provides an update on major achievements in the translation of research into medically relevant results and therapeutics. The book presents a thorough discussion of biomarkers, early human trials, and networking models, and includes institutional and industrial support systems. It also covers algorithms that have influenced all major areas of biomedical research in recent years, resulting in an increasing numbers of new chemical/biological entities (NCEs or NBEs) as shown in FDA statistics. The book is ideal for use as a guide for biomedical scientists to establish a systematic approach to translational medicine.
  • Digital
    Digital : WHO2011
    Print2011
    Background -- Scope, goal, objectives and target audience -- Global burden of NCDs -- Role of research in the implementation of the Global Strategy Action Plan -- Need for a prioritized research agenda for prevention and control of major NCDs to improve public health -- Achievable outcomes through a prioritized research agenda for prevention and control of major NCDs -- Process for the development of the WHO NCD research agenda. Initial phase of development of the WHO NCD research agenda -- Ranking process -- Finalization of WHO NCD research agenda -- Key domains for research. Major NCDs. Cardiovascular disease (CVD) -- Cancer -- Chronic respiratory diseases -- diabetes -- NCD risk factors. Tobacco control -- Nutrition, physical activity and obesity -- Cross-cutting domains. Primary health care approach for prevention and control of NCDs -- Social determinants and NCDs -- Genetics -- Promoting use of research findings to policies and practice for prevention and control of noncommunicable diseases -- Top 20 priority areas for NCD research -- Key elements required for strengthening the research capacity of low- and middle-income countries for implementation of the WHO NCD research agenda. Contents of the compact disc: -- 1. Working papers -- 2. Reports of Meetings to develop the Prioritized NCD research agenda (2008-2010) -- 3. Lists of participants -- 4. List of other contributors and institutions that participated in the process of development and review of the prioritized NCD research agenda.
  • Print
    edited by G. L. Cantoni & David R. Davies.
    Status: Not Checked OutLane Catalog Record
  • Digital
    Digital : Kargerv. 3-27, 1969-94.
  • Digital
    Task Force on Financial Conflicts of Interest in Clinical Research.
    Digital : AAMC2002
  • Digital
    volume editors, P. Porcelli, N. Sonino.
    Digital : Karger2007
    Development of a new assessment strategy in psychosomatic medicine: the diagnostic criteria for psychosomatic research / S. Fabbri ... [et al.] -- Psychosocial approach to endocrine disease / N. Sonino, E. Tomba, G.A. Fava -- Psychological factors affecting functional gastrointestinal disorders / P. Porcelli, O. Todarello -- Psychological factors affecting oncology conditions / L. Grassi ... [et al.] -- Psychological factors affecting cardiologic conditions / C. Rafanelli ... [et al.] -- Toward a biopsychosocial approach to skin diseases / A. Picardi, P. Pasquini -- Psychological factors affecting medical conditions in consultation-liaison psychiatry / A. Bellomo ... [et al.] -- Psychological factors affecting medical conditions in consultation-liaison psychiatry / A. Bellomo ... [et al.] -- Psychological factors affecting eating disorders / S. Fassino ... [et al.].
  • Digital
    Omar C.G. Gelo, Alfred Pritz, Bernd Rieken, editors.
    Digital : Springer2015
    This book provides readers with essential information on the foundations of psychotherapy research, and on its applications to the study of both psychotherapy process and outcome. The aim is to stimulate a reflection on these issues in a way that will benefit researchers and clinicians, as well as undergraduate and graduate students, at different levels and from different perspectives. Accordingly, the book presents a balanced mix of chapters summarizing the state of the art in the field from different viewpoints and covering innovative topics and perspectives, reflecting some of the most established traditions and, at the same time, emerging approaches in the field in several countries. The contributors, who were invited from among the experts in our national and international professional networks, also represent a healthy mix of leading figures and young researchers. The first part of the book addresses a number of fundamental issues in psychotherapy research at a historical, philosophical, and theoretical level. The second part of the book is concerned with research on psychotherapy processes; in this regard, both quantitative and qualitative approaches are given equal consideration in order to reflect the growing relevance of the latter. The book's third and last part examines research on psychotherapy outcomes, primarily focusing on quantitative approaches. Offering a balanced mix of perspectives, approaches and topics, the book represents a valuable tool for anyone interested in psychotherapy research.
  • Digital
    edited by Catherine Pope, Nicholas Mays.
    Digital : Wiley2006
    Qualitative methods in health research / Catherine Pope, Nicholas Mays -- Qualitative interviews / Nicky Britten -- Focus groups / Jenny Kitzinger -- Observational methods / Catherine Pope, Nicholas Mays -- Conversation analysis / Sarah Collins, Nicky Britten -- Ethical issues / Dawn Goodwin -- Analysing qualitative data / Catherine Pope, Sue Ziebland, Nicholas Mays -- Quality in qualitative health research / Nicholas Mays, Catherine Pope -- Combining qualitative and quantitative methods / Alicia O'Cathain, Kate Thomas -- Case studies / Justin Keen -- Action research / Julienne Meyer -- Consensus development methods / Nick Black -- Synthesising qualitative research / Catherine Pope and Nicholas Mays.
  • Digital
    edited by Isabelle Boutron, Philippe Ravaud, David Moher.
    Digital : CRCnetBASE2012
    "Nonpharmacological treatments include a wide variety of treatments such as surgery, technical procedures, implantable devices, nonimplantable devices, rehabilitation, psychoteherapy, and behavioral interventions. This book focuses on the methods of assessing nonpharmacological treatments, highlighting specific issues and discussing all possible design of trials. It provides practical examples to underline the issues and solutions in assessing nonpharmacological treatment in trials. Arguably the first book to exclusively explore this topic, it discusses various categories of treatments from surgical procedures to psychotherapy"--Provided by publisher.
  • Digital
    [edited by] Xin-Yuan Liu, Sidney Pestka, Yu-Fang Shi.
    Digital : ScienceDirect2012
    Cancer continues to be one of the major causes of death throughout the developed world, which has led to increased research on effective treatments. Because of this, in the past decade, rapid progress in the field of cancer treatment has been seen. Recent Advances in Cancer Research and Therapy reviews in specific details some of the most effective and promising treatments developed in research centers worldwide. While referencing advances in traditional therapies and treatments such as chemotherapy, this book also highlights advances in biotherapy including research using Interferon and Super.
  • Digital
    Marc Maesschalck.
    Digital : Wiley2017
    RRI and Governance Theory -- The Origins of Governance Theory -- Exploring Reflexive Governance Theory -- Key Strengths of a Reflexive Theory of Governance -- Promoting Reflexive Governance of RRI -- Intellectual Intervention in Society: The Key to Reflexive Governance of RRI.
  • Digital
    Committee on Advancing Pain Research, Care, and Education, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
    Digital : NAP2011
    1. Introduction -- 2. Pain as a Public Health Challenge -- 3. Care of People with Pain -- 4. Education Challenges -- 5. Research Challenges -- 6. A Blueprint for Transforming Pain Prevention, Care, Education, and Research -- Glossary -- A. Data Sources and Methods -- B. Summary of Written Public Testimony -- C. The Economic Costs of Pain in the United States -- D. Committee and Staff Biographies.

Access restricted to Stanford community

Shortcut to Licensed Content

Lane Gateway to Licensed Content

TO INSTALL, DRAG THIS BUTTON to your browser Bookmarks or Tools Bar.

What is it?

Lane Gateway to Licensed Content

Bookmark on Other Websites

Bookmark on Lane

  • TO INSTALL, RIGHT CLICK this button.
  • Select "Add to Favorites" (click “Continue” if you see a security alert)
  • From the "Create in" menu, select “Favorites Bar” (IE8, IE9) to install
  • Once installed it will look like this
  • Click "Bookmark on Lane" to bookmark any webpage
  • Your saved bookmark will appear on this page
TO INSTALL, RIGHT CLICK this button.

What is it?

Derived from Current Medical Diagnosis & Treatment, AccessMedicine's Quick Medical Diagnosis & Treatment provides topic reviews with key diagnostic and treatment features for more than 500 diseases.

A repository of medical knowledge from internal medicine, cardiology, genetics, pharmacy, diagnosis and management, basic sciences, patient care, and more.

Continuously expanding, all databases in the repository contain the latest editions of selected medical titles.

MicroMedex: Premier pharmaceutical information source containing multiple databases and drug reference tools. Of particular value is DRUGDEX Evaluations, one of the most comprehensive drug sources available.DynaMed Plus is a clinical information resource used to answer questions quickly at the point-of-care. Easy-to-interpret Levels of Evidence help clinicians rapidly determine the quality of the available evidence.

Biomedical and pharmacological abstracting and indexing database of published literature, by Elsevier. Embase® contains over 32 million records from over 8,500 currently published journals (1947-present) and is noteworthy for its extensive coverage of the international pharmaceutical and alternative/complementary medicine literature.

Scopus is the largest abstract and citation database of peer-reviewed literature: scientific journals, books and conference proceedings.A drug information resource containing: American Hospital Formulary System (AHFS), drug formulary for Lucile Packard Children's Hospital (LPCH) and Stanford Hospital & Clinics (SHC), Lexi-Drugs (adverse reactions, dosage and administration, mechanism of action, storage, use, and administration information), Lexi-Calc, Lexi-ID, Lexi-I.V. Compatibility (King Guide), Lexi-Interact, and Lexi-PALS.Cumulative Index to Nursing and Allied Health Literature (CINAHL) contains coverage of nursing and allied health literature.A knowledge database that provides access to topic reviews based on over 6000 clinically relevant articles. The evidence-based content, updated regularly, provides the latest practice guidelines in 59 medical specialties.Provides critical assessments of systematic reviews compiled from a variety of medical journals.Selects from the biomedical literature original studies and systematic reviews that are immediately clinically relevant and then summarizes these articles in an enhanced abstract with expert commentary.

Multidisciplinary coverage of over 10,000 high-impact journals in the sciences, social sciences, and arts and humanities, as well as international proceedings coverage for over 120,000 conferences.

Includes cited reference searching, citation maps, and an analyze tool.

Features systematic reviews that summarize the effects of interventions and makes a determination whether the intervention is efficacious or not.

Cochrane reviews are created through a strict process of compiling and analyzing data from multiple randomized control trials to ensure comprehensiveness and reliability.

Provides systematic coverage of the psychological literature from the 1800s to the present through articles, book chapters and dissertations.BMJ Clinical Evidence. A clinical information tool built around systematic reviews summarizing the current state of knowledge about prevention and treatment of clinical conditions.PIER (Physicians' Information and Education Resource) is a Web-based decision-support tool designed for rapid point-of-care delivery of up-to-date, evidence-based guidance for primary care physicians.Cochrane Central Register of Controlled Trials (CENTRAL) provides access to 300,000 controlled trials that have been identified the Cochrane Collaboration.Provides drug information targeted for patients.A continually updating drug monograph.The National Guideline Clearinghouse (NGC): A comprehensive database of evidence-based clinical practice guidelines and related documents.MedlinePlus: A repository of health information from the National Library of Medicine. Links are from trusted sites. No advertising, no endorsement of commercial companies or productsLPCH CareNotes via MicroMedex: Patient education handouts customized by LPCH clinical staffMicromedex Lab Advisor: Evidence based laboratory test informationA drug database organized by generic name, trade name and drug class.LPCH / Stanford Hospital Formulary.A goldmine of trusted consumer health information from the world's largest medical library.A trusted source of expert advice for and about kids, providing the information necessary to help patients and parents understand their unique needs.Provides patient handouts from the American Academy of Family Physician.Access to the Stanford Health Library for patients.Lane provides access to over 5,000 eBooks many of which provide helpful background material that will prepare you to better tackle primary literature.

Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities.

In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.

A collection of biomedical books that can be searched directly by concept, and linked to terms in PubMed abstracts.

A web-based, decision support system for infectious diseases, epidemiology, microbiology and antimicrobial chemotherapy. The database, updated weekly, currently includes 337 diseases, 224 countries, 1,147 microbial taxa and 306 antibacterial (-fungal, -parasitic, -viral) agents and vaccines.

Over 10,000 notes outline the status of specific infections within each country.

Large number of high quality software and database programming titles from O'Reilly. Other software titles are also available from Sams and Prentice Hall. Limited to 7 concurrent users.Vast collection of software and database programming titles from multiple publishers, including Microsoft Press.Largest provider of engineering-related eBooks; includes titles in computer science and biomedical engineering.Over 4,000 full-text e-books covering scientific and technical information from CRC Press and others. Many handbooks and single volume reference sources.Includes peer-reviewed life science and biomedical research protocols compiled from Methods in Molecular Biology, Methods in Molecular Medicine, Methods in Biotechnology, Methods in Pharmacology and Toxicology, Neuromethods, the Biomethods Handbook, the Proteomics Handbook, and Springer Laboratory Manuals.Contains full text access to selected biomedical and nursing books.

Provides online, full-text access to Springer's journal titles as well as journals from other publishers.

Subjects include: life sciences, chemical sciences, environmental sciences, geosciences, computer science, mathematics, medicine, physics and astronomy, engineering and economics. Also includes eBooks.

Collection of over 8 thousand fulltext titles in engineering, math, and basic and applied biomedical research. Coverage is from 1967 to the present.A library of ebooks on a wide array of topics, digitized and made available online in conjunction with the original publishers.

Stanford Medicine

CONTACT US